Showing 3991-4000 of 5771 results for "".
- 1-800 Contacts Acquires Virtual Try-On Technology Company Dittohttps://modernod.com/news/1-800-contacts-acquires-virtual-try-on-technology-company-ditto/2480334/1-800 Contacts announced the acquisition of Ditto Technologies, a provider of virtual eyewear try-on technology. The Oakland, California-based company works with partners in the vision industry to simplify shopping experiences for consumers around the world through innovative
- Ophthalmos Institute Reports Positive Efficacy Data of Eyetas' Omega 3 Fatty Acids Supplementation on Dry AMD and Stargardt Diseasehttps://modernod.com/news/ophthalmos-institute-reports-positive-efficacy-data-of-eyetas-omega-3-fatty-acids-supplementation-on-dry-amd-and-stargardt-disease/2480325/Ophthalmos Research and Educational Institute (OREI) announced positive clinical and statistically significant topline results from a small randomized, double-blind multicenter study in Europe assessing the potential effects of omega 3 fatty acids supplementation (Eyetas) in modera
- Nidek Launches Retina Scan Duo 2 OCT/Fundus Camerahttps://modernod.com/news/nidek-launches-retina-scan-duotm-2-octfundus-camera/2480323/Nidek has announced the launch of the Retina Scan Duo 2, a combined OCT and fundus camera system. The Retina Scan Duo 2 incorporates new features designed to enhance screening and clinical efficiency, in addition to user-friendly features that were incorporated from the previous model.<
- Hoya Vision Care and Haag-Streit Partner to Combat Myopiahttps://modernod.com/news/hoya-vision-care-and-haag-streit-partner-to-combat-myopia/2480322/Hoya Vision Care announced a strategic partnership with Haag-Streit to help address the global rise of myopia in children. The global sales and marketing agreement creates a preferred partnership between Hoya Vision Care and Haag-Streit to provide eye care professionals (ECPs) with Lenstar M
- Orasis Pharmaceuticals Appoints Julie Speed as Senior Vice President, Head of Strategy and Marketing to Lead Commercial Growth Planhttps://modernod.com/news/orasis-pharmaceuticals-appoints-julie-speed-as-senior-vice-president-head-of-strategy-and-marketing-to-lead-commercial-growth-plan/2480321/Orasis Pharmaceuticals announced the appointment of Julie Speed as senior vice president (SVP), head of strategy and marketing. Ms. Speed brings over two decades of leadership in eye care and will be responsible for developing the brand strategy and building the marketin
- Nicox Launches New Corporate & Investor Websitehttps://modernod.com/news/nicox-launches-new-corporate-investor-website/2480319/Nicox SA announced the launch of its redesigned corporate and investor website. The new corporate website,
- Adverum Presents Data Showing Gene Therapy Maintained Efficacy, Durability, Safety in Wet AMD Patientshttps://modernod.com/news/adverum-data-shows-gene-therapy-maintained-efficacy-durability-safety-in-wet-amd-patients/2480318/Adverum Biotechnologies announced new long-term data from the OPTIC clinical trial of ADVM-022 single, in-office intravitreal (IVT) injection gene therapy in patients requiring frequent anti-VEGF injections for their wet age-related macular degeneration (AMD). Safety and efficacy data f
- Oertli Instrumente Acquires Majority Interest in Ophthalmic Instrument Maker Domedics AGhttps://modernod.com/news/oertli-instrumente-acquires-majority-interest-in-ophthalmic-instrument-maker-domedics-ag/2480317/Oertli Instrumente announced it has acquired the majority of shares of Dattwil, Switzerland-based Domedics AG.</
- Ludwin Monz Stepping Down as CEO of Carl Zeiss Meditechttps://modernod.com/news/ludwin-monz-stepping-down-as-ceo-of-carl-zeiss-meditec/2480316/President and CEO of Carl Zeiss Meditec AG Ludwin Monz, PhD, announced that he will not be accepting another term in office, and will be stepping down from his postion effective December 31, 2021. The supervisory board has appointed Markus Weber, PhD, as the new President and
- Gyroscope Therapeutics Presents Positive Interim Phase 1/2 Data for Investigational Gene Therapyhttps://modernod.com/news/gyroscope-therapeutics-announces-presentation-of-positive-interim-phase-12-data-for-investigational-gene-therapy-gt005-at-retina-society-annual-scientific-meeting/2480312/Gyroscope Therapeutics announced positive interim data from the